Laurus Labs Limited (BOM:540222)
India · Delayed Price · Currency is INR 2,184.95
+45.15 (2.11%)
At close: Oct 28, 2026
Laurus Labs Market Cap
Laurus Labs has a market cap or net worth of 1.18 trillion as of October 28, 2026. Its market cap has increased by 132.29% in one year.
Market Cap
1.18T
Enterprise Value
1.20T
Revenue
72.70B
Global Rank
n/a
Country Rank
n/a
PE Ratio
108.02
ChartMarket Cap Chart
Since December 19, 2016, Laurus Labs's market cap has increased from 47.44B to 1.18T, an increase of 2,385.15%. That is a compound annual growth rate of 38.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 1.18T | 97.09% |
| Dec 31, 2025 | 598.16B | 84.05% |
| Dec 31, 2024 | 325.01B | 40.17% |
| Dec 29, 2023 | 231.86B | 14.74% |
| Dec 30, 2022 | 202.07B | -30.12% |
| Dec 31, 2021 | 289.18B | 52.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.40T |
| Zydus Lifesciences | 1.16T |
| Laurus Labs | 1.11T |
| Cipla | 1.09T |
| Mankind Pharma | 954.85B |
| Aurobindo Pharma | 914.85B |
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |